Development and optimization of levodopa and benzylhydrazine orally disintegrating tablets by direct compression and response surface methodology. (2nd January 2020)
- Record Type:
- Journal Article
- Title:
- Development and optimization of levodopa and benzylhydrazine orally disintegrating tablets by direct compression and response surface methodology. (2nd January 2020)
- Main Title:
- Development and optimization of levodopa and benzylhydrazine orally disintegrating tablets by direct compression and response surface methodology
- Authors:
- Zhang, Yuanyuan
Li, Zewen
Tang, Hui
Ren, Wenjie
Gao, Xin
Sun, Yangjian
Zhao, Qiu Xiang
Wang, Fanye
Liu, Junhong - Abstract:
- Abstract: The number of Parkinson's disease (PD) patients with the advanced phase and motor fluctuations is increasing. The objective of this study is developing levodopa/benzylhydrazine orally disintegrating tablets (L/B ODTs), which would provide greater convenience and ease of use than conventional tablets for these patients. In the present study, the L/B ODTs were developed successfully with an optimized formulation using response surface methodology (RSM). The direct compression technology was employed for the preparation of L/B ODTs. Considerably shorter disintegration time and faster dissolution profile were obtained under the optimum formulation with microcrystalline cellulose 25.7%, cross-polyvinylpyrrolidone 6.22% and Sodium carboxymethyl starch 5.36%. The content uniformity (%) of levodopa and benzylhydrazine was 50 ± 1.4% and 14.25 ± 0.6%, respectively. Thickness, friability, hardness and wetting time were 2.8 ± 0.05 mm, 0.46 ± 0.21%, 5.42 ± 1.1 kp and 31.2 ± 2.1 s, respectively, and all of data well comply with the General Principles of the Chinese Pharmacopeia. Mannitol of 22% in formulation could bring a pleasant taste: sweet, cool and refreshing. Almost all the volunteers felt that the ODTs had good taste, no roughness, and no gritty feeling, indicating that the ODTs prepared had good palatability, so patients will have good compliance when taking medicine.
- Is Part Of:
- Drug development and industrial pharmacy. Volume 46:Number 1(2020)
- Journal:
- Drug development and industrial pharmacy
- Issue:
- Volume 46:Number 1(2020)
- Issue Display:
- Volume 46, Issue 1 (2020)
- Year:
- 2020
- Volume:
- 46
- Issue:
- 1
- Issue Sort Value:
- 2020-0046-0001-0000
- Page Start:
- 42
- Page End:
- 49
- Publication Date:
- 2020-01-02
- Subjects:
- Levodopa -- benzylhydrazine -- orally disintegrating tablets (ODTs) -- direct compression -- response surface methodology
Pharmaceutical chemistry -- Periodicals
Pharmaceutical industry -- Periodicals
Drug Industry -- Periodicals
Technology, Pharmaceutical -- Periodicals
615.05 - Journal URLs:
- http://informahealthcare.com/loi/ddi ↗
http://informahealthcare.com ↗ - DOI:
- 10.1080/03639045.2019.1698597 ↗
- Languages:
- English
- ISSNs:
- 0363-9045
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3629.116000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 18548.xml